Brenus Pharma

An allogeneic platform designed to generate first in class immune therapy with the goal of harnessing the patient immune system and preventing resistance to cancer treatment. Our mission at Brenus is to provide a solution to cold solid tumors – today’s biggest, unmet need in oncology. The efficacy of current approaches is compromised by drug resistance within the tumor, which is a scalable process. The cell population constantly shifts during therapy, causing cancer to be considered a ‘moving target’.